Target intelligence / Profile preview

Surface-exposed primary amines on tissue proteins

Molecular classification
Chemical functional group, Protein modification site
01

Overview

Surface-exposed primary amines on tissue proteins, primarily the epsilon-amino groups of lysine residues and N-terminal alpha-amino groups, represent a critical class of reactive sites for chemical modification and therapeutic intervention (Hermanson, 2013). These amines are typically solvent-accessible and possess a lone pair of electrons that makes them potent nucleophiles at physiological pH. In the field of bioprosthetics, these groups are the primary targets for cross-linking agents like glutaraldehyde, which stabilize the extracellular matrix of animal-derived tissues to enhance durability and minimize immunogenicity upon implantation (Migneault et al., 2004; Jayakrishnan & Jameela, 1996). Beyond structural stabilization, these amines are the focal point for bioconjugation strategies, including the attachment of polyethylene glycol (PEGylation) or cytotoxic payloads in antibody-drug conjugates (ADCs) via N-hydroxysuccinimide (NHS) ester chemistry (Hermanson, 2013). Pathologically, the non-enzymatic glycation of these amines by reducing sugars leads to the formation of advanced glycation end-products (AGEs), which are key drivers of vascular stiffening and organ damage in chronic conditions such as diabetes and aging (Singh et al., 2001; Schmidt et al., 1994).

Other names
Protein primary aminesLysine epsilon-amino groupsN-terminal alpha-amino groupsSurface amines
02

Mechanism of action

Covalent modification through nucleophilic attack by the primary amine on electrophilic centers (e.g., aldehydes, NHS esters) to form stable linkages such as Schiff bases or amide bonds (Hermanson, 2013; Migneault et al., 2004).

03

Biological functions

Post-translational modificationStructural stabilizationEnzymatic catalysisProtein-protein interaction
04

Disease associations

Diabetes mellitusVascular calcificationAgingNeurodegenerative disease
05

Safety considerations

Non-specific covalent modification of off-target proteinsPotential for neoantigen formation and immunogenicityResidual toxicity of cross-linking agentsTissue calcification in bioprosthetics
06

Interacting drugs

Glutaraldehyde

4 more in the full profile.

07

Biomarkers

Glycated hemoglobin (HbA1c)Advanced glycation end-products (AGEs)Carboxymethyl-lysine (CML)

Beyond the preview

Go deeper on Surface-exposed primary amines on tissue proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surface-exposed primary amines on tissue proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call